Core Viewpoint - A class action lawsuit has been initiated against uniQure N.V. for allegedly issuing misleading statements regarding its Pivotal Study and Biologics License Application (BLA) timeline, potentially impacting shareholders who purchased shares during the specified class period [2][3]. Summary by Sections Allegations - The lawsuit claims that uniQure's management made materially false and misleading statements, including: 1. The design of the Pivotal Study was not fully approved by the FDA [2]. 2. The likelihood of delaying the BLA timeline due to the need for additional studies was downplayed [2]. 3. Consequently, the statements regarding the company's business and prospects lacked a reasonable basis [2]. Class Period and Deadlines - The class period for the lawsuit is defined as September 24, 2025, to October 31, 2025 [2]. - Shareholders are encouraged to register for the class action by April 13, 2026, to be eligible for potential recovery [3]. Next Steps for Shareholders - Registered shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [3]. - Participation in the case incurs no cost or obligation for shareholders [3]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4].

Core Viewpoint - The Gross Law Firm is notifying shareholders of uniQure N.V. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Pivotal Study and Biologics License Application timeline [1][3]. Group 1: Allegations - The complaint alleges that during the class period from September 24, 2025, to October 31, 2025, uniQure's management issued materially false and/or misleading statements [3]. - It is claimed that the design of uniQure's Pivotal Study was not fully approved by the FDA, which was not disclosed to investors [3]. - The likelihood of a delay in the Biologics License Application timeline due to the need for additional studies was downplayed, leading to a lack of reasonable basis in the company's statements about its business and prospects [3]. Group 2: Class Action Details - Shareholders are encouraged to register for the class action lawsuit by April 13, 2026, to potentially be appointed as lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of uniQure N.V. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Pivotal Study and Biologics License Application timeline [1][3]. Group 1: Allegations - The complaint alleges that during the class period from September 24, 2025, to October 31, 2025, uniQure's management issued materially false and/or misleading statements [3]. - It is claimed that the design of uniQure's Pivotal Study was not fully approved by the FDA, which was not disclosed to investors [3]. - The likelihood of a delay in the Biologics License Application timeline due to the need for additional studies was downplayed, leading to a lack of reasonable basis in the company's statements about its business and prospects [3]. Group 2: Class Action Details - Shareholders are encouraged to register for the class action lawsuit by April 13, 2026, to potentially be appointed as lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].